ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,207Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 157

$1.02M Total Retail Price of All Prescriptions

Rank: 12 out of 157

579 Patients Receiving at Least One Drug in Part D
66% Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Delaware
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 579 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 579 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $83 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Delaware
LISINOPRIL 555 403 99 1 2
LEVOTHYROXINE SODIUM 511 373 71 2 1
PRAVASTATIN SODIUM 483 283 99 3 9
METFORMIN HCL 446 301 85 4 8
FUROSEMIDE 422 331 78 5 7
OMEPRAZOLE 348 210 61 6 6
TRAMADOL HCL 343 193 88 7 17
NAMENDA 319 319 23 8 45
AMLODIPINE BESYLATE 291 218 56 9 5
CRESTOR 262 125 37 10 14
SIMVASTATIN 258 221 48 11 4
METOPROLOL SUCCINATE 239 204 42 12 12
WARFARIN SODIUM 232 214 23 13 19
CITALOPRAM HBR 228 183 35 14 29
ATORVASTATIN CALCIUM 227 164 47 15 3
GABAPENTIN 208 117 45 16 16
DONEPEZIL HCL 205 205 25 17 41
CARVEDILOL 196 139 36 18 23
MELOXICAM 189 106 58 19 62
BYSTOLIC 184 111 25 20 85
VESICARE 176 133 27 21 163
METOPROLOL TARTRATE 169 137 30 22 15
FLUTICASONE PROPIONATE 168 127 64 23 33
GLIMEPIRIDE 167 113 33 24 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 162 113 31 25 28
METFORMIN HCL ER 158 111 37 26 67
ZOLPIDEM TARTRATE 137 60 27 27 20
HYDROCHLOROTHIAZIDE 128 97 24 28 10
LORAZEPAM 126 113 37 B 29 34
PROAIR HFA 126 61 33 29 38
CELEBREX 122 89 19 31 66
CLOPIDOGREL 113 100 19 32 21
GLIPIZIDE 109 85 16 33 58
FENOFIBRATE* 108 74 18 34 71
RANITIDINE HCL 108 55 23 34 53
POLYETHYLENE GLYCOL 3350 108 67 25 34 59
ALPRAZOLAM 103 49 27 B 37 11
NEXIUM 96 57 17 38 30
ALENDRONATE SODIUM 96 73 12 38 48
PANTOPRAZOLE SODIUM 94 67 16 40 44
LOVAZA 91 63 14 41 131
POTASSIUM CHLORIDE 90 79 23 42 39
SPIRIVA 83 50 17 43 47
NIASPAN 83 36 24 43 126
BD ULTRA-FINE PEN NEEDLE 81 39 23 45 81
ATENOLOL 79 63 15 46 13
AZOR 79 63 11 46 161
NYSTATIN 78 62 26 48 117
TAMSULOSIN HCL 77 65 16 49 32
QUETIAPINE FUMARATE 77 51 12 A 49 63
LOSARTAN POTASSIUM 75 60 20 51 18
CYMBALTA 74 <11 <11 52 46
CIPROFLOXACIN HCL 73 58 56 53 61
FLUOXETINE HCL 72 <11 <11 54 69
ALLOPURINOL 72 55 14 54 40
SERTRALINE HCL 72 67* 13 54 27
NAPROXEN 67 31 21 57 96
DOXAZOSIN MESYLATE 66 <11 <11 58 99
ABILIFY 65 <11 <11 A 59 143
ENALAPRIL MALEATE 65 <11 <11 59 127
BUPROPION XL 64 15 14 61 112
TRAZODONE HCL 64 41 15 61 52
ESCITALOPRAM OXALATE 64 <11 <11 61 42
NIFEDIPINE ER 63 40 13 64 148
VENLAFAXINE HCL ER 62 <11 <11 65 122
DIOVAN 62 42 11 65 25
JANUVIA 61 <11 <11 67 54
CEFDINIR 61 36 52 67 128
AMLODIPINE BESYLATE-BENAZEPRIL 60 36 13 69 88
PAROXETINE HCL 59 54* 12 70 78
LEVETIRACETAM 59 <11 <11 70 75
LIDODERM 58 <11 <11 72 157
TIZANIDINE HCL 58 20 23 72 98
MONTELUKAST SODIUM 55 <11 <11 74 43
TOVIAZ 54 <11 <11 75 197
CLONAZEPAM 53 <11 <11 B 76 55
BUSPIRONE HCL 51 <11 <11 77 165
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.